Center for Disease Analysis Foundation Announces First Round of Grantees for the CDAF-Relink Grant
March 18 2024 - 6:29PM
Business Wire
The Center for Disease Analysis Foundation (CDA Foundation) is
thrilled to announce the first-round recipients of the CDAF-Relink
grant to connect Hepatitis B and C infected individuals in the
United States back to care. The program is funded by an
eight-million-dollar grant from Gilead Sciences (Nasdaq: GILD) as
part of Gilead’s Relink grant program. In this first round, CDA
Foundation distributed a total of 2.1 million dollars to the
following 14 grantees:
Organization
Organization Type
State
AIDS Leadership Foothills-area
Alliance
Non-profit
NC
Arizona Department of Health Services
State Health Agency
AZ
Asian Health Services
Healthcare Institution
CA
Denver Health and Hospital Authority
Healthcare Institution
CO
Family Health Centers of San Diego
Non-profit
CA
Hepatitis B Initiative of D.C.
Non-profit
MD
Kansas Department of Health and
Environment
State Health Agency
KS
Norton Healthcare
Healthcare Institution
KY
Ohio Association of Community Health
Centers
Non-profit
OH
Philadelphia FIGHT
Non-profit
PA
University of Colorado, Denver CHIP
Prevention
Healthcare Institution
CO
University of Florida College of Medicine,
Jacksonville
Healthcare Institution
FL
University of Maryland Baltimore
Healthcare Institution
MD
University of North Carolina Chapel
Hill
Healthcare Institution
NC
“As a community-based non-profit organization,” remarked
Angeline Nguyen, Program Manager at HBI, a grantee organization,
“we are honored and grateful to receive the Relink grant. This
opportunity allows us to re-engage about 1,000 of our clients who
have tested positive for HBV and/or HCV; the majority need more
assistance with finding care for their hepatitis treatment. HBI
believes this project will make a meaningful impact on the
under-served community we screen, as we assist with patient
navigation services to help clients overcome barriers for linkage
to care.”
Bridging the gap between the almost 3.3 million diagnosed but
untreated Hepatitis B and C infected individuals in the United
States and necessary care remains an important endeavor given the
link between chronic viral hepatitis infection and increasing rates
of cirrhosis, liver cancer, liver failure and premature deaths, as
well as a constellation of associated illnesses. The effort rises
in urgency considering the World Health Organization’s global
target to eliminate viral hepatitis as a major public health threat
by 2030 amidst persistent misunderstandings about the severity of
disease, lack of follow up and delayed treatment commencement.
“CDA Foundation is very proud to have been selected to
distribute these grants,” commented Homie Razavi, the Managing
Director of CDA Foundation. “Loss of diagnosed but untreated
patients is a major barrier for countries trying to achieve the
viral hepatitis elimination targets. Our grantees will work with
pregnant women, women of child-bearing age, low-income people,
people in the inner-cities, Medicaid patients, homeless, former
incarcerated, limited English proficient individuals, HIV+, LGBQIA,
immigrants, refugees, sex workers, and people who inject drugs to
link an estimated 14,000 diagnosed but untreated HCV and HBV
infected individuals back into a physician's care. We are fortunate
to have a knowledgeable independent advisory committee with
representation from the medical community, major universities, and
patient advocacy, to review and select the grantees. We are
grateful for all 35 applicants who took the time to submit a grant
and will work with the organizations who were not funded to update
their proposals for the next round of funding.”
CDA Foundation will distribute three more rounds of Relink
grants. The submission window for the second round of proposals
opened in February 2024 for programs with a duration of no more
than 18 months. Submission for the third round will open in August
2024 for programs with a duration of no more than 12 months, and
February 2025 for programs with a duration of no more than six
months. For more information, please visit
https://cdafound.org/relink or contact CDA Foundation at
relink@cdafound.org.
About Center for Disease Analysis
Foundation
CDA Foundation is a non-profit organization that seeks to help
eliminate HBV and HCV globally by 2030 by providing countries
across the world with verified epidemiological data, disease burden
and economic impact modeling, smart intervention strategies, access
to affordable diagnostics and treatments, innovative financing, and
knowledge-sharing partnerships to eliminate these deadly
infections. It works with more than 110 countries globally and 26
US states on their viral hepatitis elimination programs. CDA is
headquartered in Lafayette, Colorado.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20240318198675/en/
Homie Razavi hrazavi@cdafound.org
Gilead Sciences (NASDAQ:GILD)
Historical Stock Chart
From May 2024 to Jun 2024
Gilead Sciences (NASDAQ:GILD)
Historical Stock Chart
From Jun 2023 to Jun 2024